Trial intelligence / Profile preview

Fenoldopam for Prevention of Renal Dysfunction in Cardiac Surgery

NCT00467181Phase 2Completed

Sponsor
Summa Health
Start
Jan 2005
Primary completion
Apr 2006
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fenoldopam in chronic kidney disease (CKD), sponsored by Summa Health. Started Jan 2005; status: completed.

02

Drugs

fenoldopam
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT00467181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00467181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call